Influence of realistic inspiratory flow profiles on fine particle fractions of dry powder aerosol formulations
- PMID: 17177114
- DOI: 10.1007/s11095-006-9156-5
Influence of realistic inspiratory flow profiles on fine particle fractions of dry powder aerosol formulations
Abstract
Purpose: The purpose of the study was to determine how air flow profiles affect fine particle fractions (FPF) (<5 microm) from dry powder aerosol formulations and whether laser diffraction (LD) could be used to measure FPF of aerosols generated by variable flows.
Materials and methods: Carrier-based formulations containing 1.5% w/w micronized salbutamol base blended with the 63-90 microm fraction of alpha-lactose monohydrate or sorbitol or maltose were aerosolised from a model glass device using either a constant flow rate or a predetermined flow profile. The FPFs of the same aerosolised particles were first measured by LD and then by a liquid impinger. Volunteer inhalation airflow profiles and 3-phase (acceleration, constant flow rate and deceleration) square wave airflow profiles were generated using the Electronic Lung and an Inhalation Profile Recorder. Similar experiments were conducted for a carrier-free formulation from the Bricanyl Turbohaler.
Results: Salbutamol FPFs of all carrier-based formulations were found to increase by increasing the initial flow increase rate (FIR) from 200 to 600 l min(-1) s(-1) although they could be placed in an increasing order of maltose blend < sorbitol blend < lactose blend. A significant linear correlation was found between FPFs measured by LD and by inertial impaction (R (2) = 0.95, p < 0.01, ANOVA). For the Bricanyl Turbohaler, increasing FIR from 120 to 600 l min(-1) s(-1) for a constant peak flow rate (PFR) of 60 l min(-1) increased the mean Terbutaline FPF from 18.2% to 45.5%. For the volunteer inhalation profiles, a higher FIR tended to be associated with higher PFR, leading to a marked increase in drug FPF due to the combined effect of FIR and PFR.
Conclusion: Drug FPF from either carrier-free or carrier-based formulations is determined by both FIR and PFR. LD is a viable technique to measure the performance of dry powder aerosol formulations at realistic inspiratory flow profiles.
Similar articles
-
Humidity-induced changes of the aerodynamic properties of dry powder aerosol formulations containing different carriers.Int J Pharm. 2007 Mar 21;333(1-2):45-55. doi: 10.1016/j.ijpharm.2006.09.048. Epub 2006 Oct 1. Int J Pharm. 2007. PMID: 17064863
-
Development of a laser diffraction method for the determination of the particle size of aerosolised powder formulations.Int J Pharm. 2006 Dec 1;326(1-2):39-49. doi: 10.1016/j.ijpharm.2006.07.021. Epub 2006 Jul 16. Int J Pharm. 2006. PMID: 16942848
-
Correlation between inertial impaction and laser diffraction sizing data for aerosolized carrier-based dry powder formulations.Pharm Res. 2006 Sep;23(9):2200-9. doi: 10.1007/s11095-006-9055-9. Epub 2006 Aug 10. Pharm Res. 2006. PMID: 16900411
-
Novel alternative methods for the delivery of drugs for the treatment of asthma.Adv Drug Deliv Rev. 2003 Jul 18;55(7):793-805. doi: 10.1016/s0169-409x(03)00078-4. Adv Drug Deliv Rev. 2003. PMID: 12842601 Review.
-
What is the role of particle morphology in pharmaceutical powder aerosols?Expert Opin Drug Deliv. 2008 Aug;5(8):909-14. doi: 10.1517/17425247.5.8.909. Expert Opin Drug Deliv. 2008. PMID: 18712999 Review.
Cited by
-
Development of characteristic upper tracheobronchial airway models for testing pharmaceutical aerosol delivery.J Biomech Eng. 2013 Sep;135(9):91010. doi: 10.1115/1.4024630. J Biomech Eng. 2013. PMID: 23722698 Free PMC article.
-
Inhalation performance of physically mixed dry powders evaluated with a simple simulator for human inspiratory flow patterns.Pharm Res. 2010 Oct;27(10):2131-40. doi: 10.1007/s11095-010-0215-6. Epub 2010 Jul 14. Pharm Res. 2010. PMID: 20628789
-
Comparison of in vitro deposition of pharmaceutical aerosols in an idealized child throat with in vivo deposition in the upper respiratory tract of children.Pharm Res. 2014 Jun;31(6):1525-35. doi: 10.1007/s11095-013-1258-2. Epub 2014 Jan 7. Pharm Res. 2014. PMID: 24395403
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous